IL6 and lung cancer: Omega-3 fatty acids have anti-inflammatory effects, and in a clinical trial of lung cancer patients, omega-3 supplementation significantly reduced the levels of inflammatory factors such as CRP and IL-6 in the blood of patients during chemotherapy while improving body weight, albumin, and other nutritional indicators, which helped alleviate the systemic inflammatory response and malnutrition caused by chemotherapy (63).